- Home
- ASTC vs HCWB Comparison
ASTC vs HCWB Comparison
Compare ASTC & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- HCWB
- Stock Information
- Founded
- ASTC 1984
- HCWB 2018
- Country
- ASTC United States
- HCWB United States
- Employees
- ASTC N/A
- HCWB N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- HCWB Biotechnology: Pharmaceutical Preparations
- Sector
- ASTC Industrials
- HCWB Health Care
- Exchange
- ASTC Nasdaq
- HCWB Nasdaq
- Market Cap
- ASTC 9.8M
- HCWB 8.4M
- IPO Year
- ASTC 1995
- HCWB 2021
- Fundamental
- Price
- ASTC $5.63
- HCWB $4.41
- Analyst Decision
- ASTC
- HCWB Strong Buy
- Analyst Count
- ASTC 0
- HCWB 1
- Target Price
- ASTC N/A
- HCWB $35.00
- AVG Volume (30 Days)
- ASTC 8.4K
- HCWB 241.9K
- Earning Date
- ASTC 05-13-2025
- HCWB 08-13-2025
- Dividend Yield
- ASTC N/A
- HCWB N/A
- EPS Growth
- ASTC N/A
- HCWB N/A
- EPS
- ASTC N/A
- HCWB N/A
- Revenue
- ASTC $903,000.00
- HCWB $1,445,145.00
- Revenue This Year
- ASTC N/A
- HCWB N/A
- Revenue Next Year
- ASTC N/A
- HCWB N/A
- P/E Ratio
- ASTC N/A
- HCWB N/A
- Revenue Growth
- ASTC N/A
- HCWB N/A
- 52 Week Low
- ASTC $5.39
- HCWB $3.55
- 52 Week High
- ASTC $12.29
- HCWB $100.80
- Technical
- Relative Strength Index (RSI)
- ASTC 45.41
- HCWB 40.10
- Support Level
- ASTC $5.52
- HCWB $4.03
- Resistance Level
- ASTC $5.73
- HCWB $4.37
- Average True Range (ATR)
- ASTC 0.25
- HCWB 0.54
- MACD
- ASTC -0.01
- HCWB 0.12
- Stochastic Oscillator
- ASTC 16.96
- HCWB 45.31
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.